Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …

Venous thromboembolism is a major cause of morbidity and mortality. The impact of the US
Surgeon General's The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis …

This study integrated 5 United States healthcare claims databases to evaluate the risk of
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …

Introduction: Anticoagulation without bleeding is an ideal goal in treating thrombosis,
however, this goal has not been achieved. All current anticoagulants are associated with …

Background: Although rivaroxaban has demonstrated consistent drug levels in normal
weight and obese patients, sufficient confirmation of equal clinical effectiveness and safety is …

Many healthcare resources have been and continue to be allocated to the management of
patients with COVID-19. Therefore, the ongoing care of patients receiving oral …

In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …

The risk of venous thromboembolism following total joint arthroplasty is significantly greater
than those of other types of elective orthopaedic procedures. This risk is increased in obesity …